West Pharmaceutical Services, Inc. (BMV:WST)

BMV:WST Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Cap	349,087	440,375	481,251	324,285	647,113	389,841
Market Cap Growth	-19.09%	-8.49%	48.40%	-49.89%	65.99%	88.20%
Enterprise Value	345,350	436,653	470,790	313,269	638,808	384,264
PE Ratio	37.96	48.96	44.69	30.45	54.10	61.99
Forward PE	37.36	45.90	42.23	34.84	53.55	58.12
PEG Ratio	-	5.25	5.39	2.31	2.37	3.06
PS Ratio	6.25	8.19	8.77	6.04	12.29	9.77
PB Ratio	6.32	8.83	8.98	6.50	14.90	11.30
P/TBV Ratio	110.64	9.00	9.20	6.64	15.32	11.58
P/FCF Ratio	53.81	85.68	62.44	39.69	105.26	70.33
P/OCF Ratio	27.36	36.25	33.33	24.09	59.59	44.37
EV/Sales Ratio	6.29	8.12	8.58	5.84	12.13	9.63
EV/EBITDA Ratio	22.08	32.38	31.13	19.71	39.28	40.05
EV/EBIT Ratio	29.03	41.20	37.45	22.95	45.67	50.79
EV/FCF Ratio	53.24	84.96	61.08	38.34	103.91	69.32
Debt / Equity Ratio	0.10	0.11	0.10	0.11	0.14	0.17
Debt / EBITDA Ratio	0.41	0.42	0.38	0.37	0.37	0.63
Debt / FCF Ratio	0.88	1.09	0.75	0.72	0.98	1.09
Asset Turnover	0.78	0.77	0.79	0.83	0.93	0.84
Inventory Turnover	4.80	4.67	4.29	4.41	4.73	4.95
Quick Ratio	1.81	1.88	2.03	2.70	2.11	1.99
Current Ratio	2.78	2.79	2.88	3.70	2.93	2.73
Return on Equity (ROE)	16.89%	17.18%	20.69%	22.52%	30.63%	19.18%
Return on Assets (ROA)	12.15%	12.45%	14.98%	17.61%	21.11%	12.98%
Return on Capital (ROIC)	15.49%	17.00%	22.05%	26.34%	31.74%	18.88%
Return on Capital Employed (ROCE)	18.06%	18.23%	21.61%	25.23%	30.03%	18.97%
Earnings Yield	2.63%	2.04%	2.24%	3.28%	1.85%	1.61%
FCF Yield	1.86%	1.17%	1.60%	2.52%	0.95%	1.42%
Dividend Yield	0.38%	0.25%	0.22%	0.31%	0.15%	0.23%
Payout Ratio	13.23%	12.00%	9.61%	9.23%	7.72%	13.89%
Buyback Yield / Dilution	1.41%	2.25%	1.55%	1.11%	0.33%	0.41%
Total Shareholder Return	1.79%	2.50%	1.76%	1.42%	0.48%	0.64%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.